What’s going on in the Alzheimer’s space? This session will explore the drug pipeline, and the potential cost implications.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.